Tag Archives: Pfizer

Sanofi, GSK and Pfizer Lose Billions in Value on Zantac Woes

Sanofi, GSK and Pfizer Lose Billions in Value on Zantac Woes

(Bloomberg) — Sanofi, GSK Plc and Haleon Plc extended their declines and have lost a combined $40 billion in market value since Tuesday’s close amid mounting concerns about litigation around the recalled heartburn drug Zantac. Most Read from Bloomberg Sanofi fell as much as 13% on Thursday in trading volumes nearly 10 times the average, taking its two-day decline to 20%, the steepest drop ever over that timeframe. GSK slid as much as 12% in London, while its recent spinoff Haleon slumped… Source link

Read More »

‘You cannot stop the flow of our medicine to Russia’: Pfizer CEO Albert Bourla

‘You cannot stop the flow of our medicine to Russia’: Pfizer CEO Albert Bourla

Pfizer (PFE) announced it is halting new clinical trials in Russia and donating revenue from Russia to the Ukrainian cause, joining other big pharmaceutical companies. “Today we are announcing that effective immediately Pfizer will donate all profits of our Russian subsidiary to causes that provide direct humanitarian support to the people of Ukraine,” a company statement said. “Our medicines are medicines, not like [an] iPhone Pro, for example, or the new Mac,” Pfizer CEO Albert Bourla told… Source link

Read More »

Pfizer eyes $100B year on pandemic boon for 2022

Pfizer eyes 0B year on pandemic boon for 2022

The pandemic has been transformational for many businesses, but few can boast near-global domination the way Pfizer (PFE) can. The Pfizer/BioNTech (BNTX) vaccine accounts for 70% of all doses in the U.S. and E.U., as of February 5, according to CEO Albert Bourla Tuesday. He added that the vaccine and other Pfizer medicines reached 1.4 billion patients in 2021, or about one in six people on Earth. As a result, the company saw a 92% increase in operational revenue growth in 2021 alone, of which… Source link

Read More »

Pfizer, Moderna focus on fall 2022 vaccine plans

Pfizer, Moderna focus on fall 2022 vaccine plans

Whether or not people will need to be perpetually boosting against the coronavirus and its seemingly never-ending stream of variants remains unknown, but vaccine manufacturers are already preparing for a possible need for additional boosters in the fall. “We have to be prepared for whatever evolution gives us,” said Moderna (MRNA) CEO Stéphane Bancel. Bancel, as well as Pfizer (PFE) CEO Albert Bourla, spoke to Yahoo Finance during the annual JPMorgan Health Care conference Monday. Both… Source link

Read More »

Pfizer says antiviral pill cuts risk of severe COVID-19 by 89% – Yahoo Money

Pfizer says antiviral pill cuts risk of severe COVID-19 by 89% – Yahoo Money

By Deena Beasley    Nov 5 (Reuters) – A trial of Pfizer Inc’s experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said on Friday.    The results appear to surpass those seen with Merck & Co Inc’s pill molnupiravir, which was shown last month to halve the likelihood of dying or being hospitalized for COVID-19 patients also at high risk of serious… Source link

Read More »

‘I got the Pfizer’ vaccine, leaves door open to getting booster shot

‘I got the Pfizer’ vaccine, leaves door open to getting booster shot

Donald J. Trump joined Yahoo Finance for a wide-ranging conversation covering topics such as the U.S. economy, COVID-19 vaccines, cryptocurrencies, and his thinking on a third run for the presidency in 2024. The full interview will be released on Monday. Former President Donald Trump has revealed which COVID-19 vaccine he received before leaving the White House.   “Well, I got the Pfizer and I would have been very happy with any of them,” Trump told Yahoo Finance Live in a wide-ranging… Source link

Read More »

UPDATE 2-New Zealand reports first death linked to Pfizer COVID-19 vaccine

UPDATE 2-New Zealand reports first death linked to Pfizer COVID-19 vaccine

(Adds Pfizer response; paragraphs 6-8) By Praveen Menon WELLINGTON, Aug 30 (Reuters) – New Zealand reported its first recorded death linked to U.S. drugmaker Pfizer’s COVID-19 vaccine, the health ministry said on Monday, after a woman suffered a rare side effect leading to inflammation of her heart muscle. The news of the death comes as the country battles an outbreak of the Delta variant after nearly six months of being virus free. It followed a review by an independent panel monitoring the… Source link

Read More »

FDA’s approval of Pfizer vaccine already paving the way for mandates

FDA’s approval of Pfizer vaccine already paving the way for mandates

When Pfizer and BioNTech’s (PFE) COVID-19 vaccine on Monday became the first to receive full Food and Drug Administration approval for people 16 and older, several vaccine mandates came down just that day.  The uptick shows that legal experts and the nation’s top infectious disease expert were on target by predicting that approval would embolden businesses, governments, and schools to mandate vaccines. Just Monday, vaccine mandates came down for staff in New York City and New Jersey schools… Source link

Read More »

Pfizer, Alibaba, Nvidia, Moderna, Palantir — Stocks Buzzing On WallStreetBets Heading Into New Week

Pfizer, Alibaba, Nvidia, Moderna, Palantir — Stocks Buzzing On WallStreetBets Heading Into New Week

Heading into a new trading week, Pfizer Inc. (NYSE: PFE), Alibaba Group Holding Limited (NYSE: BABA), Nvidia Corp. (NASDAQ: NVDA) and Moderna Inc. (NASDAQ: MRNA) are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum. What Happened: Pfizer has emerged as the most-discussed stock on the forum with 106 mentions, followed by exchange-traded fund SPDR S&P 500 ETF Trust (NYSE: SPY) with 102 mentions, data from Quiver Quantitative showed. Chinese e-commerce giant… Source link

Read More »

COVID SCIENCE-Moderna may be superior to Pfizer against Delta; breakthrough odds rise with time

COVID SCIENCE-Moderna may be superior to Pfizer against Delta; breakthrough odds rise with time

Aug 9 (Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.    Moderna’s vaccine may be best against Delta    The mRNA vaccine from Pfizer and BioNTech may be less effective than Moderna’s against the Delta variant of the coronavirus, according to two reports posted on medRxiv on Sunday ahead of peer review. In a study of more than 50,000 patients in the Mayo Clinic Health System… Source link

Read More »